Microneedle pretreatment enhances the percutaneous permeation of hydrophilic compounds with high melting points

BMC Pharmacology and Toxicology

Volumn 13, Issue , 2012, Pages

  Stahl, Jessica ^a   Wohlert, Mareike ^a   Kietzmann, Manfred ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

In vitro permeation study; LogKow; Melting point; Microneedles; Non steroidal anti inflammatory drug; Physical penetration enhancement; Transdermal drug delivery

Indexed keywords

DICLOFENAC; IBUPROFEN; KETOPROFEN; METHYLENE BLUE; PARACETAMOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; IN VITRO STUDY; LIPOPHILICITY; MELTING POINT; MICRONEEDLE; MOLECULAR WEIGHT; NONHUMAN; PHYSICAL CHEMISTRY; SKIN PERMEABILITY; STRATUM CORNEUM; ULTRAVIOLET SPECTROSCOPY; ANIMAL; CATTLE; CHEMICAL PHENOMENA; CHEMISTRY; FEMALE; INTRADERMAL DRUG ADMINISTRATION; NEEDLE; SKIN ABSORPTION; TRANSITION TEMPERATURE;

ACETAMINOPHEN; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATTLE; DICLOFENAC; FEMALE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IBUPROFEN; KETOPROFEN; NEEDLES; SKIN ABSORPTION; TRANSITION TEMPERATURE;

EID: 84872035866     PISSN: 20506511     EISSN: None     Source Type: Journal    
DOI: 10.1186/2050-6511-13-5     Document Type: Article

References (39)

1. Hadgraft J. Skin, the final frontier 32. IntJPharm 2001, 224:1-18.
2. Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman E, Elias PM. Human stratum corneum lipids: characterization and regional variations 3. JLipid Res 1983, 24:120-130.
3. Williams AC, Barry BW. Skin absorption enhancers. Crit Rev Ther Drug Carrier Syst 1992, 9:305-353.
4. Singh J, Singh S. Transdermal iontophoresis: effect of penetration enhancer and iontophoresis on drug transport and surface characteristics of human epidermis. Curr Probl Dermatol 1995, 22:179-183.
5. Srinivasan V, Higuchi WI, Sims SM, Ghanem AH, Behl CR. Transdermal iontophoretic drug delivery: mechanistic analysis and application to polypeptide delivery. J Pharm Sci 1989, 78:370-375. 10.1002/jps.2600780506, 2664125.
6. Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA, Revilla-Vazquez AL. Electroporation as an efficient physical enhancer for skin drug delivery. J Clin Pharmacol 2009, 49:1262-1283. 10.1177/0091270009344984, 19717723.
7. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci 1998, 87:922-925. 10.1021/js980042+, 9687334.
8. Kaushik S, Hord AH, Denson DD, McAllister DV, Smitra S, Allen MG, Prausnitz MR. Lack of pain associated with microfabricated microneedles. Anesth Analg 2001, 92:502-504. 10.1213/00000539-200102000-00041, 11159258.
9. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-based vaccines. Curr Top Microbiol Immunol 2009, 333:369-393. 10.1007/978-3-540-92165-3_18, 2904604, 19768415.
10. Badran MM, Kuntsche J, Fahr A. Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation. Eur J Pharm Sci 2009, 36:511-523. 10.1016/j.ejps.2008.12.008, 19146954.
11. Wu Y, Qiu Y, Zhang S, Qin G, Gao Y. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility. Biomed Microdevices 2008, 10:601-610. 10.1007/s10544-008-9171-x, 18324474.
12. Martanto W, Davis SP, Holiday NR, Wang J, Gill HS, Prausnitz MR. Transdermal delivery of insulin using microneedles in vivo. Pharm Res 2004, 21:947-952.
13. Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci 2006, 29:82-88. 10.1016/j.ejps.2006.05.011, 16828268.
14. Lee JW, Park JH, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008, 29:2113-2124. 10.1016/j.biomaterials.2007.12.048, 2293299, 18261792.
15. Martanto W, Moore JS, Kashlan O, Kamath R, Wang PM, O'Neal JM, Prausnitz MR. Microinfusion using hollow microneedles. Pharm Res 2006, 23:104-113. 10.1007/s11095-005-8498-8, 16308670.
16. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 2004, 56:581-587. 10.1016/j.addr.2003.10.023, 15019747.
17. Zhou CP, Liu YL, Wang HL, Zhang PX, Zhang JL. Transdermal delivery of insulin using microneedle rollers in vivo. Int J Pharm 2010, 392:127-133. 10.1016/j.ijpharm.2010.03.041, 20347024.
18. McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG, Prausnitz MR. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A 2003, 100:13755-13760. 10.1073/pnas.2331316100, 283494, 14623977.
19. Verbaan FJ, Bal SM, van den Berg DJ, Groenink WH, Verpoorten H, Luttge R, Bouwstra JA. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin. J Control Release 2007, 117:238-245. 10.1016/j.jconrel.2006.11.009, 17196697.
20. ChemIDPlus advance http://chem.sis.nlm.nih.gov/chemidplus/.
21. Ludewig T, Michel G, Gutte G. Histological and histochemical investigations on the structure of udder skin of cattle with special reference to changes during in vivo udder perfusion models. Dtsch Tierarztl Wochenschr 1996, 103:501-505.
22. Stahl J, Niedorf F, Kietzmann M. The correlation between epidermal lipid composition and morphologic skin characteristics with percutaneous permeation: an interspecies comparison of substances with different lipophilicity. J Vet Pharmacol Ther 2011, 34:502-507. 10.1111/j.1365-2885.2010.01246.x, 21906081.
23. Niedorf F, Schmidt E, Kietzmann M. The automated, accurate and reproducible determination of steady-state permeation parameters from percutaneous permeation data. Altern Lab Anim 2008, 36:201-213.
24. Verbaan FJ, Bal SM, van den Berg DJ, Dijksman JA, van Hecke M, Verpoorten H, van den Berg A, Luttge R, Bouwstra JA. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Release 2008, 128:80-88. 10.1016/j.jconrel.2008.02.009, 18394741.
25. Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 2002, 8:415-419. 10.1038/nm0402-415, 11927950.
26. Gomaa YA, Morrow DI, Garland MJ, Donnelly RF, El-Khordagui LK, Meidan VM. Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. Toxicol In Vitro 2010, 24:1971-1978. 10.1016/j.tiv.2010.08.012, 20732409.
27. Donnelly RF, Singh TR, Tunney MM, Morrow DI, McCarron PA, O'Mahony C, Woolfson AD. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 2009, 26:2513-2522. 10.1007/s11095-009-9967-2, 2900181, 19756972.
28. Park JH, Choi SO, Seo S, Choy YB, Prausnitz MR. A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm 2010, 76:282-289. 10.1016/j.ejpb.2010.07.001, 20624460.
29. Oh JH, Park HH, Do KY, Han M, Hyun DH, Kim CG, Kim CH, Lee SS, Hwang SJ, Shin SC, Cho CW. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur J Pharm Biopharm 2008, 69:1040-1045. 10.1016/j.ejpb.2008.02.009, 18411045.
30. Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH. Ibuprofen Transport into and through Skin from Topical Formulations: In Vitro-In Vivo Comparison 1. J Invest Dermatol 2006, 127:135-142.
31. Kasting G, Smith R, Cooper E, Shroot B, Schaefer H. Effect of lipid solubility and molecular size on percutaneous absorption. In Pharmacology and the Skin. Volume 1 1987, 138-153. Karger, Basel.
32. Nielsen JB, Nielsen F, Sorensen JA. In vitro percutaneous penetration of five pesticides-effects of molecular weight and solubility characteristics 3. AnnOccupHyg 2004, 48:697-705.
33. Nielsen JB. Percutaneous penetration through slightly damaged skin. Arch Dermatol Res 2005, 296:560-567. 10.1007/s00403-005-0555-y, 15834614.
34. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: A novel approach to transdermal drug delivery. J Pharm Sci 1999, 88:948.
35. Singh TR, Garland MJ, Cassidy CM, Migalska K, Demir YK, Abdelghany S, Ryan E, Woolfson AD, Donnelly RF. Microporation techniques for enhanced delivery of therapeutic agents. Recent Pat Drug Deliv Formul 2010, 4:1-17. 10.2174/187221110789957174, 19807682.
36. Fiala S, Brown MB, Jones SA. Dynamic in-situ eutectic formation for topical drug delivery. J Pharm Pharmacol 2011, 63:1428-1436.
37. Stott PW, Williams AC, Barry BW. Mechanistic study into the enhanced transdermal permeation of a model beta-blocker, propranolol, by fatty acids: a melting point depression effect. Int J Pharm 2001, 219:161-176. 10.1016/S0378-5173(01)00645-7, 11337176.
38. Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008, 35:193-202. 10.1016/j.ejps.2008.06.016, 18657610.
39. Banga AK. Microporation applications for enhancing drug delivery. Expert Opin Drug Deliv 2009, 6:343-354. 10.1517/17425240902841935, 19348604.